4.7 Article

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection

Journal

CLINICAL INFECTIOUS DISEASES
Volume 53, Issue 12, Pages 1271-1279

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir725

Keywords

-

Funding

  1. Swiss National Science Foundation [324730-130865]
  2. European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [FP7/2007-2013, 223131]
  3. Union Bank of Switzerland
  4. Tibotec, Switzerland
  5. ViiV Healthcare, Switzerland
  6. Vontobel Stiftung
  7. Roche
  8. Abbott
  9. Bristol-Myers Squibb
  10. Gilead Sciences
  11. GlaxoSmithKline
  12. ViiV Healthcare
  13. Tibotec
  14. Merck Sharp Dohme
  15. Gilead
  16. Roche Diagnostics
  17. Boehringer Ingelheim
  18. Pfizer
  19. TRB Chemedica
  20. Swiss National Science Foundation (SNF) [324730_130865] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Background. In the context of sexual transmission of human immunodeficiency virus type 1 (HIV-1), current findings suggest that the mucosal barrier is the major site of viral selection, transforming the complex inoculum to a small, homogeneous founder virus population. We analyzed HIV-1 transmission in relation to viral and host characteristics within the Zurich primary HIV-1 infection study. Methods. Clonal HIV-1 envelope sequences (on average 16 clones/patient) were isolated from the first available plasma samples during the early phase of infection from 145 patients with primary HIV-1 infection. Phylogenetic and tropism analyses were performed. Differences of viral diversities were investigated in association with several parameters potentially influencing HIV-1 transmission, eg, concomitant sexually transmitted infections (STIs) and mode of transmission. Results. Median viral diversity within env C2-V3-C3 region was 0.39% (range 0.04%-3.23%). Viral diversity did not correlate with viral load, but it was slightly correlated with the duration of infection. Neither transmission mode, gender, nor STI predicted transmission of more heterogeneous founder virus populations that were found in 16 of 145 patients (11%; diversity >1%). Only 2 patients (1.4%) were assuredly infected with CXCR4-tropic HIV-1 within a R5/X4-tropic-mixed population, as revealed and confirmed using several genotypic prediction algorithms and phenotypic assays. Conclusions. Our findings suggest that transmission of multiple HIV-1 variants might be a complex process that is not dependent on mucosal factors alone. CXCR4-tropic viruses can be sexually transmitted in rare instances, but their clinical relevance remains to be determined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available